Buzzi Unicem S.p.A.
Buzzi Unicem S.p.A. (BZZUY) Financial Performance & Income Statement Overview
Explore the financials of Buzzi Unicem S.p.A. (BZZUY), including yearly and quarterly data on income, cash flow, and balance sheets.
Buzzi Unicem S.p.A. (BZZUY) Income Statement & Financial Overview
Review Buzzi Unicem S.p.A. BZZUY income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $2.26B | $1.03B | $1.03B | $2.17B |
| Cost of Revenue | $1.36B | $588.29M | $588.29M | $1.29B |
| Gross Profit | $896.67M | $439.29M | $439.29M | $874.33M |
| Gross Profit Ratio | $0.40 | $0.43 | $0.43 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $324.64M | $160.46M | $160.46M | $322.87M |
| Operating Expenses | $341.84M | $226.59M | $183.91M | $352.78M |
| Total Costs & Expenses | -$1.70B | $814.88M | $772.20M | $1.65B |
| Interest Income | $43.17M | $37.58M | $12.31M | $0.00 |
| Interest Expense | $27.59M | $21.10M | $0.00 | $0.00 |
| Depreciation & Amortization | $145.03M | $127.31M | $58.09M | $119.79M |
| EBITDA | $662.49M | $607.53M | $265.02M | $325.69M |
| EBITDA Ratio | $0.29 | $0.59 | $0.26 | $0.30 |
| Operating Income | $554.83M | $206.94M | $206.94M | $521.55M |
| Operating Income Ratio | $0.25 | $0.20 | $0.20 | $0.24 |
| Other Income/Expenses (Net) | -$67.87M | $252.18M | $60.75M | -$227.54M |
| Income Before Tax | $486.96M | $459.11M | $267.69M | $507.36M |
| Income Before Tax Ratio | $0.22 | $0.45 | $0.26 | $0.23 |
| Income Tax Expense | $37.23M | $113.51M | $56.75M | $52.41M |
| Net Income | $520.57M | $210.87M | $210.87M | $535.45M |
| Net Income Ratio | $0.23 | $0.21 | $0.21 | $0.25 |
| EPS | $2.86 | $2.28 | $1.14 | $2.89 |
| Diluted EPS | $2.86 | $2.28 | $1.14 | $2.89 |
| Weighted Avg Shares Outstanding | $182.02M | $184.94M | $184.94M | $185.13M |
| Weighted Avg Shares Outstanding (Diluted) | $182.02M | $184.94M | $184.94M | $185.13M |
Financial performance has remained strong, with revenue growing from $2.17B in Q4 2023 to $2.26B in Q4 2024. Gross profit continued to perform well, with margins at 40% in the latest quarter. Operating income reached $554.83M in Q4 2024, holding a steady 25% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $662.49M. Net income rose to $520.57M, keeping EPS at $2.86. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan